13 Einträge gefunden

1. Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial

   1. Trapp, Elisabeth K
   2. Fasching, Peter A
   3. Fehm, Tanja
   4. Schneeweiss, Andreas
   5. Mueller, Volkmar
   6. Harbeck, Nadia
   7. Lorenz, Ralf

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials

   1. Furlanetto, Jenny
   2. Marmé, Frederik
   3. Seiler, Sabine
   4. Thode, Christian
   5. Untch, Michael
   6. Schmatloch, Sabine
   7. Schneeweiss, Andreas

   2021 - Forschungsinformationssystem des UKE
3. AGO Algorithms for the Treatment of Breast Cancer: Update 2021

   1. Schneeweiss, Andreas
   2. Fasching, Peter A
   3. Fehm, Tanja
   4. Gerber, Bernd
   5. Jackisch, Christian
   6. Loibl, Sibylle
   7. Schmidt, Marcus

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Update Breast Cancer 2020 Part 5 - Moving Therapies From Advanced to Early Breast Cancer Patients

   1. Lux, Michael P
   2. Schneeweiss, Andreas
   3. Hartkopf, Andreas D
   4. Müller, Volkmar
   5. Janni, Wolfgang
   6. Belleville, Erik
   7. Stickeler, Elmar

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2020 - Forschungsinformationssystem des UKE
7. Update Breast Cancer 2020 Part 1 - Early Breast Cancer:Consolidation of Knowledge About Known Therapies

   1. Schneeweiss, Andreas
   2. Hartkopf, Andreas D
   3. Müller, Volkmar
   4. Wöckel, Achim
   5. Lux, Michael P
   6. Janni, Wolfgang
   7. Ettl, Johannes

   2020 - Forschungsinformationssystem des UKE
8. Update Breast Cancer 2020 Part 3 - Early Breast Cancer

   1. Huober, Jens
   2. Schneeweiss, Andreas
   3. Hartkopf, Andreas D
   4. Müller, Volkmar
   5. Lux, Michael P
   6. Janni, Wolfgang
   7. Ettl, Johannes

   2020 - Forschungsinformationssystem des UKE
9. Circulating tumor cells in metastatic breast cancer: clinical relevance and biological potential

   1. Arkadius, Polasik
   2. Tzschaschel, Marie
   3. Schochter, Fabienne
   4. Friedl, Thomas W. P.
   5. Rack, Brigitte
   6. Hartkopf, Andreas
   7. Fasching, Peter A

   2019 - Forschungsinformationssystem des UKE
10. Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment

    1. Bauer, Emanuel C A
    2. Schochter, Fabienne
    3. Widschwendter, Peter
    4. DeGregorio, Amelie
    5. Andergassen, Ulrich
    6. Friedl, Thomas W P
    7. Fasching, Peter A

    2018 - Forschungsinformationssystem des UKE
11. Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?

    1. Polasik, Arkadius
    2. Tzschaschel, Marie
    3. Schochter, Fabienne
    4. de Gregorio, Amelie
    5. Friedl, Thomas W P
    6. Rack, Brigitte
    7. Hartkopf, Andreas

    2017 - Forschungsinformationssystem des UKE
12. Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer Secondary Analysis of the GeparSixto Randomized Clinical Trial

    1. Hahnen, Eric
    2. Lederer, Bianca
    3. Hauke, Jan
    4. Loibl, Sibylle
    5. Kröber, Sandra
    6. Schneeweiss, Andreas
    7. Denkert, Carsten

    2017 - Forschungsinformationssystem des UKE
13. Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)

    1. Untch, Michael
    2. Huober, Jens
    3. Jackisch, Christian
    4. Schneeweiss, Andreas
    5. Brucker, Sara Y
    6. Dall, Peter
    7. Denkert, Carsten

    2017 - Forschungsinformationssystem des UKE